{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-124381","form_type":"8-K","ticker":"PMVP","cik":"0001699382","company_name":"PMV Pharmaceuticals, Inc.","filed_at":"2023-04-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.098939+00:00","generated_at":"2026-06-16T06:37:03.358613+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"confidence":"high","headline":"PMV Pharmaceuticals adopts amended bylaws effective June 8, 2023","bullets":["Amended and Restated Bylaws approved by Board on April 24, 2023, effective at 2023 annual meeting.","Updates advance notice procedures for director nominations, including Rule 14a-19 compliance evidence requirement.","Revises provisions on stockholder meetings, board action by written consent, and director/committee matters to conform to Delaware law.","Also updates various provisions to conform to recent amendments to DGCL and makes ministerial clarifications."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-124381","json":"https://secwatch.observer/filing/0001193125-23-124381.json","markdown":"https://secwatch.observer/filing/0001193125-23-124381.md","text":"https://secwatch.observer/filing/0001193125-23-124381.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1699382/000119312523124381/0001193125-23-124381-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1699382/000119312523124381/d452268d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T06:37:03.358613+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a7aa5e78fa7a7657a503af0e275f02e6c30ff2f2","claim":"PMV Pharmaceuticals, Inc.: Amended and restated bylaws to update advance notice procedures, conform to DGCL amendments, and make ministerial changes (effective 2023-06-08).","evidence_excerpt":"to be effective on June 8, 2023, the date of the Company’s 2023 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1699382/000119312523124381/0001193125-23-124381-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-06-08"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}